edit: I may have been too critical here - I'm planning to re-read the piece tomorrow. It does play into a few things that annoy/worry me. To me,...
Not particularly interesting....
Sorry - rambling post that's largely just me writing to work out what I think. There are lots of things surrounding ME/CFS that I think make the...
I think I'm genuinely still on the fence about the new paper too. There are things that concern me about it, and the politics surrounding it and...
Drawing attention to patients jumping onto a risky treatment lacking a solid evidence base is going to encourage the 'fad disease' narrative. It...
I posted some reasons for concern about this paper, but I think we should stay away from any personal stuff about other peoples' health problems.
I'm not sure I understand your point then. Are you saying that I was inaccurate about something? Past endorsements can still serve as current...
5 years ago isn't that long, especially if there's been a failure to apologise for the problems of the past. PACE first came out in 2011, and...
I don't know why some assume O'Dowd has valuable expertise for patients, rather than just attracting funding? The PACE trial seems to be the...
What makes you say that at this point? I feel like I've still got no idea of the details of this.
I don't think that it would be a good idea to make a complaint about something like this. The Guardian has done so much worse!
I don't follow why it would be a self-fulfilling prophesy to have similar results rather than it being expected that nonblinded trials would be...
Thanks a lot of John for his persistence on this (and also to those who first raised this issue long ago). I wonder if it would be worth a...
Just to be clear, I don't think this is anything to do with Cochrane, other than their publishing of information from clinicaltrials.gov:...
Wonder if that's the same Jonathan Price who did Cochrane's CFS reviews?
She played an important role in PACE, and offered some shit attempts to defend it that showed she really had no idea what she was talking about....
Thanks Michiel - I knew that my approach was highly inefficient, but I was a bit interested in going through the trials of neurological...
I don't think we really know, particularly as it's possible China had been understating the problem initially, meaning that more realistic recent...
Some quick notes on the second trial where the MS cochrane review rated participants as being blinded, Cerasa 2012: 'Computer-Assisted Cognitive...
I think that everyone should be cautious about the way this paper is assessed until it has been really dug into. There are fair reasons for...
Separate names with a comma.
